Blood Coagulation Abnormalities in COVID-19 (Corona Virus Disease-19) Patients
1 other identifier
observational
125
1 country
2
Brief Summary
The role of the coagulation parameters in predicting the severity of COVID-19 disease will be assessed
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2021
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2021
CompletedFirst Submitted
Initial submission to the registry
July 26, 2021
CompletedFirst Posted
Study publicly available on registry
July 29, 2021
CompletedJuly 29, 2021
July 1, 2021
4 months
July 26, 2021
July 27, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
correlation of disease severity with results of laboratory test
The results of blood coagulation profile will be correlated with degree of severity of illness
Baseline results of coagulation profile and baseline disease severity assessment
Secondary Outcomes (1)
Agreement of abnormalities in coagulation profile with measured inflammatory markers
baseline measurement of inflammatory markers
Study Arms (2)
Mild cases
Patients with confirmed COVID-19 and with mild disease
Severe cases
Patients with confirmed COVID-19 and with severe disease
Interventions
Venous blood sample for measurement of blood coagulation profile
Eligibility Criteria
Cases with confirmed COVID 19 disease
You may qualify if:
- ● Confirmed cases with COVID 19
You may not qualify if:
- ● Known history of blood coagulopathy disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (2)
Sohag University
Sohag, 82425, Egypt
Sohag University
Sohag, 82524, Egypt
Related Publications (3)
Fauci AS, Lane HC, Redfield RR. Covid-19 - Navigating the Uncharted. N Engl J Med. 2020 Mar 26;382(13):1268-1269. doi: 10.1056/NEJMe2002387. Epub 2020 Feb 28. No abstract available.
PMID: 32109011BACKGROUNDTang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
PMID: 32073213BACKGROUNDTerpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, Psaltopoulou T, Gerotziafas G, Dimopoulos MA. Hematological findings and complications of COVID-19. Am J Hematol. 2020 Jul;95(7):834-847. doi: 10.1002/ajh.25829. Epub 2020 May 23.
PMID: 32282949BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hend mohamed A Esmaeel, M.D
Sohag Univesity
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant professor
Study Record Dates
First Submitted
July 26, 2021
First Posted
July 29, 2021
Study Start
February 1, 2021
Primary Completion
May 31, 2021
Study Completion
May 31, 2021
Last Updated
July 29, 2021
Record last verified: 2021-07